-
Study aim
-
comparision the effect of several target of transcranial direct current stimulation (tDCS) including M1, DLPFC and M1-DLPFC on balance in people with Parkinson's disease (PD)
-
Design
-
Double blind Cross-over trial. block randomization
-
Settings and conduct
-
This study will be conducted in Parkinson's disease association in Isfahan. 25 patients with PD will recieve four conditions include M1, DLPFC, M1-DLPFC, and sham in a counterbalance random order
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
(1) Patients with Parkinson's Disease
(2) Age 40 or older
(3) Stages 2,3 on the Hoehn and Yahr scale
(4) Ability to walk independently for at least 10 m
(5) Montreal Cognitive Assessment score ≥ 24
(6) No change in medication prescription during and since 3 weeks before the study
Exclusion criteria:
(1) Any deformity of the lower limbs
(2) using central nervous system medications other than for PD, e.g., antiepileptic or antidepressant drugs
(3) Contraindications of using tDCS, such as having metal implants in the head, pacemaker, pregnancy, history of brain damage, history of epilepsy and seizures, and intermittent headaches
(4) patients with neurological diseases other than PD, psychiatric diseases, or patients with drug or alcohol abuse.
-
Intervention groups
-
the active set-up, the tDCS device will apply a constant current of for 20 minutes. the intensity of tDCS will be 3 mA. For M1 stimulation, The anode will be place over Cz and the cathode will be applied over the left shoulder. For DLPFC stimulation, anode and cathode electrodes will be placed over F3 and right shoulder respectively. The sham tDCS set-up will receive the same electrode placement and duration of stimulation, but the device will be turned off after 30 seconds.
-
Main outcome variables
-
Before/after
Berg balance scale;
Mini-BESTest;
Timed Up and Go(single/dual task)